Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-25

FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVEGA (PALIPERIDONE)

Snippet

SUPPL AP for INVEGA (PALIPERIDONE)